Management of Low Hepatitis B Antibody Titers After Vaccination in Healthy Adults

Initial Assessment and Testing

The Centers for Disease Control and Prevention recommends testing anti-HBs levels 1-2 months after completing the initial 3-dose vaccination series to determine if protective immunity (≥10 mIU/mL) has been achieved 1
A non-responder is defined as having anti-HBs <10 mIU/mL after the complete primary series 1
Ensure the patient received the appropriate age-specific dose: for adults ≥20 years, this is 10 μg (Recombivax HB) or 20 μg (Engerix-B) per dose, as recommended by the Centers for Disease Control and Prevention 2

Administer one additional dose of hepatitis B vaccine as the first-line approach for non-responders, which produces protective antibody levels in 25-50% of initial non-responders, according to the American College of Physicians 1
If anti-HBs remains <10 mIU/mL after the single booster, complete a second full 3-dose series using the standard 0, 1, and 6-month schedule, achieving seroprotection in 44-100% of non-responders, as recommended by the Centers for Disease Control and Prevention 1, 3

Age >40 years significantly reduces vaccine response, with only 75% of people aged 60+ developing protective antibodies compared to >95% in younger adults, according to the American Geriatrics Society 1
Immunocompetent adults who previously achieved anti-HBs ≥10 mIU/mL do NOT need routine antibody testing or booster doses, even if titers subsequently fall below 10 mIU/mL, as stated by the Centers for Disease Control and Prevention 2

Immunocompromised patients, hemodialysis patients, and those with chronic liver disease require different dosing schedules, regular antibody monitoring, and booster doses when titers fall below 10 mIU/mL, according to the Infectious Diseases Society of America 6, 7